Individualized, Additively Manufactured Drug-Releasing External Ear Canal Implant for Prevention of Postoperative Restenosis: Development, In Vitro Testing, and Proof of Concept in an Individual Curative Trial

• Ngā kaituhi matua: Farnaz Matin-Mann (Author), Ziwen Gao (Author), Jana Schwieger (Author), Martin Ulbricht (Author), Vanessa Domsta (Author), Stefan Senekowitsch (Author), Werner Weitschies (Author), Anne Seidlitz (Author), Katharina Doll (Author), Meike Stiesch (Author), Thomas Lenarz (Author), Verena Scheper (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-06-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Postoperative restenosis in patients with external ear canal (EEC) atresia or stenosis is a common complication following canaloplasty. Our aim in this study was to explore the feasibility of using a three dimensionally (3D)-printed, patient-individualized, drug ((dexamethasone (DEX)), and ciproflox...